Page last updated: 2024-11-07

7-fluoro-4-nitrobenzo-2-oxa-1,3-diazole

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID122123
SCHEMBL ID315294
MeSH IDM0102424

Synonyms (41)

Synonym
7-fluoro-4-nitrobenzofurazan
c6h2fn3o3
29270-56-2
4-fluoro-7-nitrobenzofurazan
4-fluoro-7-nitrobenzofurazan, >=98% (elemental analysis)
nbd-f
4-fluoro-7-nitro-2,1,3-benzoxadiazole
4-fluoro-4-nitro-1h-2,1,3-benzoxadiazole;4-fluoro-7-nitrobenzofurazan
A819857
7-fluoro-4-nitrobenzo-2-oxa-1,3-diazole
4-fluoro-7-nitrobenzofurazane
4-fluoro-4-nitro-2,1,3-benzoxadiazole
l5vs78su5j ,
nbd-f cpd
unii-l5vs78su5j
nbd-fluoride
4-fluoro-7-nitrobenzo-2-oxa-1,3-diazole
benzofurazan, 4-fluoro-7-nitro-
FT-0618498
4-fluoro-7-nitrobenzo[c][1,2,5]oxadiazole
S10237
AKOS015903171
SCHEMBL315294
PGZIDERTDJHJFY-UHFFFAOYSA-N
AM85705
W-200023
4-fluoro-7-nitrobenz-2-oxa-1,3-diazole
2,1,3-benzoxadiazole, 4-fluoro-7-nitro-
HY-D0785
CS-7995
AC-24650
DTXSID20183521
mfcd00010196
GS-3328
4-fluoro-7-nitrobenzofurazan, bioreagent, suitable for fluorescence, >=98.0% (hplc)
SY057147
Z1255431019
4-fluoro-7-nitro-[2,1,3]-benzoxadiazole
EN300-219591
AKOS040744096
PD100582

Research Excerpts

Pharmacokinetics

ExcerptReferenceRelevance
" This method was successfully applied to a pharmacokinetic study after oral administration of a dose (150 mg) of ranitidine."( A sensitive and rapid determination of ranitidine in human plasma by HPLC with fluorescence detection and its application for a pharmacokinetic study.
Tuncel, M; Ulu, ST, 2012
)
0.38

Dosage Studied

ExcerptRelevanceReference
" The proposed procedure was successfully applied to the determination of ramipril in both tablet dosage form and in plasma."( Use of 7-fluoro-4-nitrobenzo-2-oxo-1,3-diazole (NBD-F) for the determination of ramipril in tablets and spiked human plasma.
Al-Majed, AA; Al-Zehouri, J, 2001
)
0.31
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (94)

TimeframeStudies, This Drug (%)All Drugs %
pre-199013 (13.83)18.7374
1990's19 (20.21)18.2507
2000's43 (45.74)29.6817
2010's19 (20.21)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 9.94

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index9.94 (24.57)
Research Supply Index4.67 (2.92)
Research Growth Index4.62 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (9.94)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (0.95%)5.53%
Reviews1 (0.95%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other103 (98.10%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]